Hugo M. Vargas

4.4k total citations
120 papers, 2.5k citations indexed

About

Hugo M. Vargas is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hugo M. Vargas has authored 120 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Cardiology and Cardiovascular Medicine, 43 papers in Molecular Biology and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hugo M. Vargas's work include Cardiac electrophysiology and arrhythmias (41 papers), Ion channel regulation and function (21 papers) and Receptor Mechanisms and Signaling (17 papers). Hugo M. Vargas is often cited by papers focused on Cardiac electrophysiology and arrhythmias (41 papers), Ion channel regulation and function (21 papers) and Receptor Mechanisms and Signaling (17 papers). Hugo M. Vargas collaborates with scholars based in United States, United Kingdom and Switzerland. Hugo M. Vargas's co-authors include Yusheng Qu, John E. Kelsey, Lisa Galati, Andrew Gorman, Gautam Chaudhuri, Jean‐Pierre Valentin, Ray W. Chui, Lily Zhou, Steven M. Parnes and Fernando Camacho and has published in prestigious journals such as Journal of the American College of Cardiology, Stroke and Brain Research.

In The Last Decade

Hugo M. Vargas

114 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugo M. Vargas United States 29 851 685 518 347 320 120 2.5k
G. Zürcher Switzerland 27 888 1.0× 305 0.4× 553 1.1× 318 0.9× 261 0.8× 42 3.0k
R. Massingham Belgium 27 966 1.1× 316 0.5× 614 1.2× 543 1.6× 163 0.5× 86 2.1k
Michael J. Antonaccio United States 28 1.0k 1.2× 1.1k 1.6× 573 1.1× 431 1.2× 212 0.7× 96 2.4k
R R Ruffolo United States 20 1.5k 1.8× 746 1.1× 906 1.7× 666 1.9× 109 0.3× 44 2.8k
Katsuji Oguchi Japan 28 920 1.1× 217 0.3× 455 0.9× 399 1.1× 200 0.6× 175 2.4k
Mao‐Hsiung Yen Taiwan 31 937 1.1× 588 0.9× 170 0.3× 924 2.7× 351 1.1× 113 3.1k
J.P. Maffrand France 29 1.3k 1.6× 922 1.3× 685 1.3× 504 1.5× 873 2.7× 56 3.9k
Elizabeth A. Kowaluk United States 32 1.0k 1.2× 325 0.5× 544 1.1× 1.1k 3.1× 151 0.5× 63 3.1k
R. Towart Germany 24 1.6k 1.8× 898 1.3× 811 1.6× 478 1.4× 139 0.4× 50 2.7k
Fred De Clerck Belgium 33 1.1k 1.3× 1.1k 1.7× 539 1.0× 656 1.9× 398 1.2× 120 3.2k

Countries citing papers authored by Hugo M. Vargas

Since Specialization
Citations

This map shows the geographic impact of Hugo M. Vargas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo M. Vargas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo M. Vargas more than expected).

Fields of papers citing papers by Hugo M. Vargas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo M. Vargas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo M. Vargas. The network helps show where Hugo M. Vargas may publish in the future.

Co-authorship network of co-authors of Hugo M. Vargas

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo M. Vargas. A scholar is included among the top collaborators of Hugo M. Vargas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo M. Vargas. Hugo M. Vargas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friedrichs, Gregory S., D.E. Ackley, Matthew Clark, et al.. (2024). Reevaluating safety pharmacology respiratory studies within the ICH S7A core battery: A multi-company evaluation of preclinical utility and clinical translation. Regulatory Toxicology and Pharmacology. 153. 105706–105706. 3 indexed citations
2.
Qu, Yusheng, et al.. (2024). Scientific Review of the Proarrhythmic Risks of Oligonucleotide Therapeutics: Are Dedicated ICH S7B/E14 Studies Needed for Low‐Risk Modalities?. Clinical Pharmacology & Therapeutics. 116(1). 96–105. 10 indexed citations
3.
Qu, Yusheng, et al.. (2022). Time Is a Critical Factor When Evaluating Oligonucleotide Therapeutics in hERG Assays. Nucleic Acid Therapeutics. 33(2). 132–140. 4 indexed citations
4.
Engwall, Michael J., Nancy Everds, James R. Turk, & Hugo M. Vargas. (2021). The Effects of Repeat-Dose Doxorubicin on Cardiovascular Functional Endpoints and Biomarkers in the Telemetry-Equipped Cynomolgus Monkey. Frontiers in Cardiovascular Medicine. 8. 587149–587149. 5 indexed citations
5.
Vargas, Hugo M., et al.. (2021). The in vivo QTc core assay: An evaluation of QTc variability, detection sensitivity and implications for the improvement of conscious dog and non-human primate telemetry studies. Journal of Pharmacological and Toxicological Methods. 109. 107067–107067. 15 indexed citations
6.
Zhou, Xin, Yusheng Qu, Elisa Passini, et al.. (2020). Blinded In Silico Drug Trial Reveals the Minimum Set of Ion Channels for Torsades de Pointes Risk Assessment. Frontiers in Pharmacology. 10. 1643–1643. 28 indexed citations
7.
Pugsley, Michael K., Simon Authier, John Koerner, et al.. (2018). An overview of the safety pharmacology society strategic plan. Journal of Pharmacological and Toxicological Methods. 93. 35–45. 4 indexed citations
8.
Qu, Yusheng, et al.. (2013). Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay. Journal of Pharmacological and Toxicological Methods. 68(1). 74–81. 28 indexed citations
9.
Authier, Simon, Hugo M. Vargas, Michael J. Curtis, Mark Holbrook, & Michael K. Pugsley. (2013). Safety pharmacology investigations in toxicology studies: An industry survey. Journal of Pharmacological and Toxicological Methods. 68(1). 44–51. 35 indexed citations
10.
Chui, Ray W., Katayoun Derakhchan, & Hugo M. Vargas. (2012). Comprehensive analysis of cardiac arrhythmias in telemetered cynomolgus monkeys over a 6 month period. Journal of Pharmacological and Toxicological Methods. 66(2). 84–91. 10 indexed citations
11.
Vargas, Hugo M., Hamid Amouzadeh, & Michael J. Engwall. (2012). Nonclinical strategy considerations for safety pharmacology: evaluation of biopharmaceuticals. Expert Opinion on Drug Safety. 12(1). 91–102. 35 indexed citations
12.
Piccini, Jonathan P., David J. Whellan, Brian R. Berridge, et al.. (2009). Current challenges in the evaluation of cardiac safety during drug development: Translational medicine meets the Critical Path Initiative. American Heart Journal. 158(3). 317–326. 93 indexed citations
13.
Williams, Edwin F., et al.. (2003). Midfacial Rejuvenation Via a Minimal-Incision Brow-lift Approach. Archives of Facial Plastic Surgery. 5(6). 470–478. 32 indexed citations
14.
Vargas, Hugo M., et al.. (2000). More Aggressive Behavior of Squamous Cell Carcinoma of the Anterior Tongue in Young Women. The Laryngoscope. 110(10). 1623–1626. 67 indexed citations
15.
Vargas, Hugo M., Lisa Galati, & Steven M. Parnes. (2000). A Pilot Study Evaluating the Treatment of Postparotidectomy Sialoceles With Botulinum Toxin Type A. Archives of Otolaryngology - Head and Neck Surgery. 126(3). 421–421. 77 indexed citations
16.
Vargas, Hugo M. & Andrew Gorman. (1995). Vascular alpha-1 adrenergic receptor subtypes in the regulation of arterial pressure. Life Sciences. 57(25). 2291–2308. 63 indexed citations
17.
Kelsey, John E. & Hugo M. Vargas. (1993). Medial septal lesions disrupt spatial, but not nonspatial, working memory in rats.. Behavioral Neuroscience. 107(4). 565–574. 69 indexed citations
18.
Vargas, Hugo M., et al.. (1992). Amide, urea, and carbamate analogs of the muscarinic agent [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride. Journal of Medicinal Chemistry. 35(15). 2787–2798. 13 indexed citations
19.
Brezenoff, Henry E., Yong‐Fu Xiao, & Hugo M. Vargas. (1988). A comparison of the central and peripheral antimuscarinic effects of atropine and methylatropine injected systematically and into the cerebral ventricles. Life Sciences. 42(8). 905–911. 29 indexed citations
20.
González-Martín, G, et al.. (1986). Pharmacokinetics of gentamicin in children with nephrotic syndrome.. PubMed. 24(10). 555–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Zürcher Breakdown of academic impact, for papers by R. Massingham Breakdown of academic impact, for papers by Michael J. Antonaccio Breakdown of academic impact, for papers by R R Ruffolo Breakdown of academic impact, for papers by Katsuji Oguchi Breakdown of academic impact, for papers by Mao‐Hsiung Yen Breakdown of academic impact, for papers by J.P. Maffrand Breakdown of academic impact, for papers by Elizabeth A. Kowaluk Breakdown of academic impact, for papers by R. Towart Breakdown of academic impact, for papers by Fred De Clerck
Rankless by CCL
2026